KRMD vs. IRMD, BFLY, SIBN, KIDS, TMCI, SMLR, NNOX, CLPT, TCMD, and DCTH
Should you be buying KORU Medical Systems stock or one of its competitors? The main competitors of KORU Medical Systems include Iradimed (IRMD), Butterfly Network (BFLY), SI-BONE (SIBN), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), Nano-X Imaging (NNOX), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry.
KORU Medical Systems vs.
Iradimed (NASDAQ:IRMD) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.
92.3% of Iradimed shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 37.1% of Iradimed shares are held by insiders. Comparatively, 21.7% of KORU Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Iradimed currently has a consensus price target of $60.00, indicating a potential upside of 1.40%. KORU Medical Systems has a consensus price target of $4.50, indicating a potential upside of 10.02%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, analysts plainly believe KORU Medical Systems is more favorable than Iradimed.
In the previous week, KORU Medical Systems had 17 more articles in the media than Iradimed. MarketBeat recorded 21 mentions for KORU Medical Systems and 4 mentions for Iradimed. KORU Medical Systems' average media sentiment score of 0.59 beat Iradimed's score of 0.56 indicating that KORU Medical Systems is being referred to more favorably in the news media.
Iradimed received 208 more outperform votes than KORU Medical Systems when rated by MarketBeat users. Likewise, 64.78% of users gave Iradimed an outperform vote while only 64.71% of users gave KORU Medical Systems an outperform vote.
Iradimed has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500.
Iradimed has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks.
Iradimed has a net margin of 26.12% compared to KORU Medical Systems' net margin of -37.42%. Iradimed's return on equity of 23.99% beat KORU Medical Systems' return on equity.
Summary
Iradimed beats KORU Medical Systems on 13 of the 19 factors compared between the two stocks.
Get KORU Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
KORU Medical Systems Competitors List
Related Companies and Tools
This page (NASDAQ:KRMD) was last updated on 1/20/2025 by MarketBeat.com Staff
Free KRMD Stock Alerts